Plan To Share Clinical Data Could Stifle EU Drug Innovation
By Rachel Slajda (December 19, 2012, 12:00 AM EST) -- The European Medicines Agency's announcement that it plans to proactively release drug sponsors' clinical trial data in 2014 has pharmaceutical companies on edge, with experts saying drug companies could avoid seeking approval for their products in European markets, stifling innovation and potentially depriving patients of access to drugs.
The EMA has declared that clinical trial data is not commercial confidential information, and held a public meeting in November on its proposal to release clinical trial data after drugs go through the agency's marketing authorization process. The agency said it will take input from advisory groups through April, with an eye toward...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!